VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
VTAE was delisted on the 24th of October, 2016.
76 hedge funds and large institutions have $284M invested in VITAE PHARMACEUTICALS INC COMMON STOCK in 2015 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 27 increasing their positions, 16 reducing their positions, and 14 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
83% more capital invested
Capital invested by funds: $155M → $284M (+$129M)
69% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 16
43% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 14
9% more funds holding
Funds holding: 70 → 76 (+6)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$9.88M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$8.58M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.72M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$3.34M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$1.83M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$6.55M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
-$4.33M |
| 3 |
JP Morgan Chase
New York
|
-$2.69M |
| 4 |
California State Teachers Retirement System (CalSTRS)
West Sacramento,
California
|
-$2.4M |
| 5 |
HLA
Hamilton Lane Advisors
Conshohocken,
Pennsylvania
|
-$1.97M |
VTAE Hedge Fund Activity: Q4 2015 in Review
76 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) for Q4 2015, worth a combined $284M — up 83% from $155M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new VTAE positions and 14 closed out — a net gain of 6 holders — while 27 added to existing stakes and 16 trimmed.
The largest buyer was Adage Capital Partners, adding an estimated $9.88M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $6.55M sold.
- 76 institutional investors held VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) as of Q4 2015, up from 70 in Q3 2015.
- Funds reported $284M of VITAE PHARMACEUTICALS INC COMMON STOCK stock for Q4 2015, up 83% quarter-over-quarter.
- 20 funds opened new VITAE PHARMACEUTICALS INC COMMON STOCK positions in Q4 2015 and 14 closed out, a net change of +6 holders.
- The largest VITAE PHARMACEUTICALS INC COMMON STOCK buyer in Q4 2015 was Adage Capital Partners, an estimated $9.88M added.
- The largest VITAE PHARMACEUTICALS INC COMMON STOCK seller in Q4 2015 was Point72 Asset Management, an estimated $6.55M sold.
Based on aggregated 13F filings for Q4 2015.